Showing search results for

The tools of artificial intelligence (AI) are enabling McGovern researchers to ask new kinds of questions and solve more complex problems — and that’s leading to new insights into how the brain works and how mental illness might be more effectively managed. “I can’t think of any facet [of brain research] where there isn’t an […]

Consciousness transfer, the hypothetical process of moving a human mind to a digital medium, has been a cornerstone of science fiction movies and books for decades. But as AI advances, questions about whether human consciousness could be transferred to a machine have moved from science fiction to serious academic debate. The human brain is widely […]

On June 9, the McGovern Institute convened leaders in science, biotechnology, and patient advocacy for RareNet 2026, a first-of-its-kind symposium aimed at dismantling the barriers between laboratory discovery and life-changing treatments for rare brain disorders. Over 300 million people worldwide live with rare disorders—most affecting the brain and nervous system. Yet the vast majority lack […]

Chronic pain is a widespread and complex condition that affects nearly one-quarter of the US population. Despite its prevalence, chronic pain is often undertreated, leading many people to depend on addictive medications such as opioids. Our researchers are creating detailed maps of the neural circuits involved in pain perception as well as the emotional suffering […]